Imperial College London

Dr Michael A. ("Mike") Skinner

Faculty of MedicineDepartment of Infectious Disease

Reader in Virology
 
 
 
//

Contact

 

+44 (0)20 7594 3938m.skinner Website

 
 
//

Assistant

 

Mrs Yasmin Mallu +44 (0)20 7594 3972

 
//

Location

 

315Medical SchoolSt Mary's Campus

//

Summary

 

Collaborators

Dr Colin Butter, Institute for Animal Health,Compton,Berks.RG20 7NN, 2006

Prof Pete KaiserChair in Animal Infectious Diseases, The Roslin Institute,University of Edinburgh,Easter Bush Veterinary Centre,Roslin, MidlothianEH25 9RGScotland, 2000

Prof. Adrian Hill & Dr Sarah Gilbert, University of Oxford, 1999

Prof Steve Goodbourn, St George's Hospital, University of London, 2003

Guest Lectures

Genetic screens to identify avian interferon-response modulators encoded by Fowlpox virus, Institute for Animal Health, Compton LaboratoryNewburyBerks.RG20 7NN, 2010

Avipoxviruses: interferon modulation and screening of vaccine vectors, Recombinant vaccines - Strategies for candidate discovery and vaccine delivery, BioPark Hertfordshire,Broadwater Road,Welwyn Garden City,Hertfordshire,AL7 3AX, 2010

Broadscale phenotypic screens to identify candidate poxvirus mutants as improved candidate vaccine vectors, Institute of Bioscience (IBS)Universiti Putra Malaysia, Universiti Putra Malaysia,43400 Serdang, Selangor, Malaysia, 2009

Increasing the therapeutic potential of recombinant poxvirus vaccines to protect against avian influenza H5N1, Virology Department, Veterinary Laboratories Agency (VLA)Woodham LaneNew HawAddlestoneSurrey KT15 3NB, 2009

Increasing the therapeutic potential ofrecombinant poxvirus vaccines to protectagainst avian influenza H5N1, UEA School of MedicineInstitute of Biomedical and Clinical SciencesInfection & Immunity, University of East AngliaNorwichNR4 7TJ, 2009

Targeted mutations to improve thepotential efficacy of recombinantavipoxvirus vaccines, Department for Infectious Diseases, North Manchester General HospitalDelaunay's RoadManchester M8 5RB, 2009

Avian poxviruses as safe, non-replicating vaccine vectors in humans & animals, Merseyside Immunology Group, University of Liverpool, School of Medicine, 2005

Clinical and veterinary use of recombinant Fowlpox virus vaccines against influenza H5N1 & other diseases, Division of Infection and Immunity, UCL, Windeyer Institute, London, 2006

Atypical poxviruses - molecular biology and vaccinevectors, University of Sussex, Depts of Biochemistry and Genetics & Development, Falmer, Brighton, 2006

Clinical and veterinary use of recombinant Fowlpox virus vaccines against influenza H5N1 & other diseases, Imperial College London, School of Medicine, Wright-Fleming Institute, St Mary's Campus, London, 2006